Cargando…

Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma

OBJECTIVE: AT-rich interactive domain 1A (ARID1A) plays an important role as a tumor suppressor gene in ovarian clear cell carcinoma (OCCC), but the clinical application of ARID1A remains unclear. The aim of this study was to analyze clinicopathological parameters, molecular interactions and immune-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Un Suk, Min, Kyueng-Whan, Kim, Dong-Hoon, Kwon, Mi Jung, Park, HoHyun, Jang, Hyung Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767648/ https://www.ncbi.nlm.nih.gov/pubmed/33185044 http://dx.doi.org/10.3802/jgo.2021.32.e3

Ejemplares similares

High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer
por: Kim, Hyung Suk, et al.
Publicado: (2021)

High KDM1A Expression Associated with Decreased CD8+T Cells Reduces the Breast Cancer Survival Rate in Patients with Breast Cancer
por: Kim, Hyung Suk, et al.
Publicado: (2021)

High WHSC1L1 Expression Reduces Survival Rates in Operated Breast Cancer Patients with Decreased CD8+ T Cells: Machine Learning Approach
por: Kim, Hyung-Suk, et al.
Publicado: (2021)

Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma
por: Kwon, Byung Su, et al.
Publicado: (2018)

Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression
por: Choi, Jae Yoon, et al.
Publicado: (2017)

Low gamma‐butyrobetaine dioxygenase (BBOX1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma: a machine learning approach
por: Kim, Kyu‐Shik, et al.
Publicado: (2023)

Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
por: Takahashi, Kazuaki, et al.
Publicado: (2021)

High BMI1 Expression with Low CD8+ and CD4+ T Cell Activity Could Promote Breast Cancer Cell Survival: A Machine Learning Approach
por: Chung, Yumin, et al.
Publicado: (2021)

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
por: Sato, Emi, et al.
Publicado: (2018)

Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
por: Maeda, Daichi, et al.
Publicado: (2010)

High SLC2A1 expression associated with suppressing CD8 T cells and B cells promoted cancer survival in gastric cancer
por: Min, Kyueng-Whan, et al.
Publicado: (2021)

ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
por: Berns, Katrien, et al.
Publicado: (2018)

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017)

CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
por: Kawahara, Naoki, et al.
Publicado: (2021)

High polymerase ε expression associated with increased CD8+T cells improves survival in patients with non-small cell lung cancer
por: Min, Kyueng-Whan, et al.
Publicado: (2020)

Higher Acid-Base Imbalance Associated with Respiratory Failure Could Decrease the Survival of Patients with Scrub Typhus during Intensive Care Unit Stay: A Gene Set Enrichment Analysis
por: Moon, Kyoung Min, et al.
Publicado: (2019)

Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
por: Yano, Mitsutake, et al.
Publicado: (2019)

SMARCA4 loss irrelevant for ARID1A mutated ovarian clear cell carcinoma: A case report
por: Wagner, Samantha Kay, et al.
Publicado: (2023)

Tumor Suppressive Role of the PRELP Gene in Ovarian Clear Cell Carcinoma
por: Dozen, Ai, et al.
Publicado: (2022)

Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells
por: Niimi, Kaoru, et al.
Publicado: (2014)

The Primary Effect on the Proteome of ARID1A-mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-transcriptional Level
por: Goldman, Aaron R., et al.
Publicado: (2016)

Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
por: Ge, Huijuan, et al.
Publicado: (2021)

Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer
por: Kinose, Yasuto, et al.
Publicado: (2023)

Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer
por: Yokoyama, Yoshihito, et al.
Publicado: (2014)

Mandibular clear cell odontogenic carcinoma
por: Kwon, Ik Jae, et al.
Publicado: (2015)

Cancer-associated fibroblasts are associated with poor prognosis in solid type of lung adenocarcinoma in a machine learning analysis
por: Min, Kyueng-Whan, et al.
Publicado: (2021)

Progressive Increase of Regulatory T Cells and Decrease of CD8+ T Cells and CD8+ T Cells/Regulatory T Cells Ratio during Colorectal Cancer Development
por: Jang, Tae Jung
Publicado: (2013)

Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: Ha, U-Syn, et al.
Publicado: (2018)

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signaling
por: Chandler, Ronald L., et al.
Publicado: (2015)

GLS1 is a Protective Factor in Patients with Ovarian Clear Cell Carcinoma and its Expression Does Not Correlate with ARID1A-mutated Tumors
por: Clemente, Valentino, et al.
Publicado: (2022)

ADAM9 is over‐expressed in human ovarian clear cell carcinomas and suppresses cisplatin‐induced cell death
por: Ueno, Mari, et al.
Publicado: (2018)

Diagnostic Roles of Immunohistochemical Markers CK20, CD44, AMACR, and p53 in Urothelial Carcinoma In Situ
por: Yoo, Daeseon, et al.
Publicado: (2023)

Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinoma
por: Lewin, S, et al.
Publicado: (2012)

The target therapy of ovarian clear cell carcinoma
por: Jin, Ying, et al.
Publicado: (2014)

The Tumor Microenvironment of Clear-Cell Ovarian Cancer
por: Devlin, Michael-John, et al.
Publicado: (2022)

Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
por: Lin, Yu-Chien, et al.
Publicado: (2020)

PARP inhibitors in the treatment of ARID1A mutant ovarian clear cell cancer: PI3K/Akt1-dependent mechanism of synthetic lethality
por: Yakovlev, Vasily A., et al.
Publicado: (2023)

Publisher Correction: Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: Ha, U-Syn, et al.
Publicado: (2018)

Organ-Specific Differentiation of Human Adipose-Derived Stem Cells in Various Organs of Xenotransplanted Rats: A Pilot Study
por: Park, Jung Ho, et al.
Publicado: (2022)

Persistent elevation of postoperative neutrophil-to-lymphocyte ratio: A better predictor of survival in gastric cancer than elevated preoperative neutrophil-to-lymphocyte ratio
por: Min, Kyueng-Whan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uchb1b10302cnndsi93qc9mnsk